Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.

Thomas, Jesse C; Kersh, Ellen N; Gernert, Kim M; Shafer, William M; Raphael, Brian H

Thomas, Jesse C; Kersh, Ellen N; Gernert, Kim M; Shafer, William M; Raphael, Brian H.

Afiliação

Thomas JC; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kersh EN; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Gernert KM; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Shafer WM; Department of Microbiology and Immunology and The Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Raphael BH; Laboratories of Bacterial Pathogenesis, Veterans Affairs Medical Center, Decatur, Georgia, USA.

J Infect Dis ; 221(5): 852-853, 2020 02 18.

Article em En | MEDLINE | ID: mdl-31581287

Assuntos

Azitromicina; Gonorreia; Azitromicina/farmacologia; Cefalosporinas/farmacologia; Evolução Molecular; Gonorreia/tratamento farmacológico; Gonorreia/epidemiologia; Humanos; Neisseria gonorrhoeae/genética; Estados Unidos/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gonorreia / Azitromicina Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google